The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was redirect to Pfizer. (non-admin closure) ASTIG️🎉 _{(HAPPY 2022)} 13:00, 28 January 2022 (UTC)[reply]

Anacor (edit | talk | history | protect | delete | links | watch | logs | views) – (View log | edits since nomination)

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

I nominated this for deletion in 2000 due to what I saw as a lack of notability at the time and it was kept. Although the main crux of the keep votes came down to insulting me over the nomination, saying it must be notable because it it developed two FDA approved drugs, or similar WP:ILIKEIT and WP:INTERESTING arguments. No one that voted keep really discussed the sourcing except to provide a couple of extremely trivial ones that related to them being bought out by Pfizer and an article that has to do with a compound in one of their drugs that has nothing to do with them except for saying in the article that they came up with it. Both of which are extremely WP:MILL. As drug companies routinely create pharmaceutical compounds and get bought out by other drug companies. So, I'm re-nominating this in the hopes that a better consensus, based on an actual discussion about the companies notability or lack of it, can occur this time around. Hopefully without the insults and other nonsense that occurred in the last discussion.

Just to throw it out there, in the original AfD I suggested redirecting or merging this to Pfizer as an ATD. I still think that doing so is a good option compared to doing nothing. Since there is some coverage of the company, even if it's extremely trivial. I just don't think there is enough to justify a stand alone article though. So I'm fine with anyone voting merge or redirect if they think it's justified compared to deleting the article outright.Adamant1 (talk) 02:40, 14 January 2022 (UTC)[reply]

• Note: This discussion has been included in the list of Companies-related deletion discussions. Shellwood (talk) 02:48, 14 January 2022 (UTC)[reply]
• Note: This discussion has been included in the list of California-related deletion discussions. Shellwood (talk) 02:48, 14 January 2022 (UTC)[reply]

@Shellwood: Do you happen to know why the "AfDs for this article" sidebox includes articles that have nothing to do with this one in it? --Adamant1 (talk) 03:59, 14 January 2022 (UTC)[reply]

• Delete. This should be one sentence in Pfizer, and it already is. Most of the information in this article is background that is already covered elsewhere and has nothing to do with the subject; what is left is routine information about an acquired company. FalconK (talk) 22:05, 17 January 2022 (UTC)[reply]

Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, ✗plicit 12:54, 21 January 2022 (UTC)[reply]

• Redirect to Pfizer, with merging of any information deemed absolutely necessary; nothing of value will be lost. BD2412 T 18:21, 21 January 2022 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.